Pain Management Stewardship Programs,Part I: A Review of Legislative and Regulatory Changes

Abstract

Background: Opioid use is classified as an epidemic by many due to the impact of these medications on society. Federal and state laws for prescribing and dispensing opioids have changed rapidly in a short period of time to hopefully balance proper pain control with their use. Pharmacy directors must be informed of these rapid changes to effectively work as part of any opioid stewardship team. Objective: The objective of this study was to provide foundational leadership guidance to pharmacy directors on current opioid legislation, literature, and best practices to assist in improving opioid use. Methods: A review of the literature from 2003 to the present was conducted along with collating important up to date resources and other publications that provide foundational information to help support a comprehensive management of opioid use. A summary of these data has been collated into an easy to use table and summarized throughout this article. Conclusion: The information provided in this article helps to properly inform pharmacy leaders to the resources available to improve the prescribing, dispensing, and monitoring of opioids and alternatives.

Keywords

opioid opioid epidemic pain management pharmacists legislation

Get full access to this article

View all access options for this article.

References

Paulozzi

Baldwin

Franklin

. CDC grand rounds: prescription drug overdoses—a U.S. epidemic. Date unknown. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm. Accessed July 15, 2017.

Fischer

Keates

Buhringer

et al. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109(2):177-181.

Vermeulen

Eddington

Gourdine

et al. ASHP foundation pharmacy forecast 2019: strategic planning advice for pharmacy departments in hospitals and health systems. Am J Health Syst Pharm. 2019;76:71-100.

Weiss

Elixhauser

Barrett

et al. Opioid-related inpatient stays and emergency department visits by state, 2009-2014. HCUP Statistical Brief #219. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.jsp. Published December 2016. Accessed July 23, 2019.

Addressing prescription drug abuse in the United States. https://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Accessed July 19, 2017.

Meldrum

ML.

The ongoing opioid prescription epidemic: historical context. Am J Public Health. 2016;106(8):1365-1366.

Mularski

White-Chu

Overbay

Miller

Asch

Ganzini

Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006;21(6):607-612.

The Department of Veterans Affairs. Pain as the 5th vital sign toolkit. https://www.va.gov/PAINMANAGEMENT/docs/Pain_As_the_5th_Vital_Sign_Toolkit.pdf. Published 2000. Accessed September 21, 2017.

Prescription opioid overdose data. Date unknown. https://www.cdc.gov/drugoverdose/data/overdose.html. Accessed July 30, 2017.

10.

Wilkerson

Kim

Windsor

Mareiniss

DP.

The opioid epidemic in the United States. Emerg Med Clin North Am. 2016;34(2):e1-e23.

11.

US Department of Health and Human Services. Addressing prescription drug abuse in the United States: current activities and future opportunities. Date unknown. https://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Accessed August 15, 2017.

12.

Ghafoor

Phelps

Pastor

Implementation of a pain medication stewardship program. Am J Health Syst Pharm. 2013;70(23):2070, 2074-2075.

13.

Zellmer

Allen

Knoer

et al. Pharmacy forecast 2017: strategic planning advice for pharmacy departments in hospitals and health systems. Am J Health Syst Pharm. 2016;73:e617-143.

14.

Dowell

Haegerich

Chou

CDC guideline for prescribing opioids for chronic pain—United States. 2016;2016(1):1-49.

15.

The Joint Commission. Joint commission enhances pain assessment and management requirements for accredited hospitals. Date unknown. https://www.jointcommission.org/assets/1/18/Joint_Commission_Enhances_Pain_Assessment_and_Management_Requirements_for_Accredited_Hospitals1.PDF. Accessed March 29, 2019.

16.

US Food & Drug Administration. Questions and answers: FDA approves a risk evaluation and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics. https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm309742.htm. Published October 20, 2015. Accessed March 29, 2019.

17.

Califf

Woodcock

Ostroff

A proactive response to prescription opioid abuse. N Engl J Med. 2016;374(15):1480-1485.

18.

Drug Enforcement Administration. DEA reduces amount of opioid controlled substances to be manufactured in 2017. https://www.dea.gov/divisions/hq/2016/hq100416.shtml. Published October 4, 2016. Accessed March 29, 2019.

19.

Community Anti-Drug Coalitions of America. The comprehensive addiction and recovery act (CARA). Date unknown. http://www.cadca.org/comprehensive-addiction-and-recovery-act-cara. Accessed March 29, 2019.

20.

Congress.gov. Public law 114-198. Comprehensive Addiction and Recovery Act of 2016. Date unknown. https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf. Accessed March 29, 2019.

21.

Prescription Drug Monitoring Program Training and Technical Assistance Center State PDMP information. Date unknown. http://www.pdmpassist.org/content/pdmp-maps-and-tables. Accessed April 3, 2019.

22.

Connecticut Department of Consumer Protection. Prescription monitoring program. Date unknown. http://www.ct.gov/dcp/cwp/view.asp?a=1620&q=411378&dcpNav_GID=1881. Accessed April 3, 2019.

23.

Office of Legislative Research. Connecticut’s opioid drug abuse laws. Date unknown. https://www.cga.ct.gov/2016/rpt/pdf/2016-R-0143.pdf. Accessed April 3, 2019.

24.

National Conference of State Legislators (NCSL). Prescribing policies: states confront opioid overdose epidemic. http://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx. Published October 31, 2018. Accessed April 3, 2019.

25.

New York State Department of Health . Laws and regulations. Date unknown. https://www.health.ny.gov/professionals/narcotic/laws_and_regulations/. Accessed April 3, 2019.

26.

Office of Legislative Research. Research report: Connecticut’s seven-day limit on opioid prescriptions. https://www.cga.ct.gov/2016/rpt/pdf/2016-R-0232.pdf. Accessed April 3, 2019

27.

Office of Legislative Research. Research report: Connecticut’s limit on opioid drug prescriptions. https://www.cga.ct.gov/2017/rpt/pdf/2017-r-0189.pdf. Published September, 2017. Accessed April 3, 2019.

28.

Maine Legislature Public Law. Chapter 488: an act to prevent opiate abuse by strengthening the controlled substances prescription monitoring program. Date unknown. https://legislature.maine.gov/legis/bills/bills_127th/chapters/PUBLIC488.asp. Accessed April 3, 2019.

29.

State of Ohio Board of Pharmacy. For prescribers—new limits on prescription opioids for acute pain. http://www.pharmacy.ohio.gov/Documents/Pubs/Special/PrescriptionOpioids/For%20Prescribers%20-%20New%20Limits%20on%20Prescription%20Opioids%20for%20Acute%20Pain.pdf. Published February 22, 2019. Accessed April 3, 2019.

30.

Vermont Department of Health. Rule governing the prescribing of opioids for pain. http://www.healthvermont.gov/sites/default/files/documents/pdf/REG_opioids-prescribing-for-pain.pdf. Published March 1, 2019. Accessed April 3, 2019.

31.

State of Rhode Island Department of Health. Safe opioid prescribing. Date unknown. http://www.health.ri.gov/healthcare/medicine/about/safeopioidprescribing/#apain. Accessed August 28, 2017.

32.

Davis

Carr

Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug Alcohol Depend. 2015;157:112-120.

33.

The Network for Public Health Law. Legal interventions to reduce overdose mortality: naloxone access and overdose Good Samaritan laws. https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf. Published December 31, 2018. Accessed April 3, 2019.

34.

National Conference of State Legislatures. Drug overdose immunity and good Samaritan laws. http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx. Published June, 2017. Accessed April 3, 2019.

35.

Harm Reduction Coalition. Naloxone program case studies. Date unknown. http://harmreduction.org/issues/overdose-prevention/tools-best-practices/naloxone-program-case-studies/. Accessed August 12, 2017.

36.

Wheeler

EJT

Gilbert

Davidson

. Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a2.htm?s_cid=mm6423a2_w. Published June 2015. Accessed August 25, 2017.

37.

Oliva

Christopher

Wells

et al. Opioid overdose education and naloxone distribution: development of the Veterans health administration’s national program. J Am Pharm Assoc (2003). 2017;57(2 suppl):S168-S179.e4.

38.

Kerensky

Walley

AY.

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know. Addict Sci Clin Pract. 2017;12.